Clinical Trial Update: Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update describes a nucleoside switch study in virologically controlled HIV patients with decreasing CD4 counts who previously received tenofovir d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Therapeutic Concepts | Conditions: HiV1- Positive | Phase 4 | Status: COMPLETED